Clinical Trial Update: Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating lamotrigine extended-release added to existing seizure therapies in patients with partial-onset seizures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Lamictal Extended-Release (lamotrigine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy, Epilepsy, Partial | Phase 3 | Status: COMPLETED